Skip to content
thestock.space

On 6 Nov 2026, Omkar Pharmachem was priced at ₹5.66, or 0.2× trailing earnings, against an industry P/E of 16.3×, and the shares are 81% below their 52-week high. Its ROCE of 0.5% is the lowest among the 7 largest Specialty Business Services peers, and net profit fell 15% a year over 3 years, though net profit is above operating profit, which points to a one-off gain. It is a small-cap company with a market cap of ₹5.71 Cr, ranked 51st of 52 Specialty Business Services companies by market cap; the shares fell 79% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹5.66
Day high
₹5.66
Day low
₹5.66
Prev. close
₹5.95
Volume
1

Health check

4 to check
  • ReturnsBehind

    −79.0% over a year, better than 1 of 7 peers.

  • Price tagDistorted

    A one-off gain inflates profit, so P/E isn’t comparable right now.

  • GrowthShrinking

    Profit −14.9% a year over 3 years.

  • ProfitabilityWeak

    ROCE 0.5% vs peer median 16.6%.

  • Balance sheetn/a

    Balance sheet figures aren’t reported.

  • Red flags5 to check

    Return on equity is low at 0.5%.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Specialty Business Services

51 listed peers. Screen the industry

Small cap

₹5.71 Cr, #51 of 52 in its industry by size.

Defensive

Beta 0.23 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Jun 2026: sales ₹0 Cr · profit ₹0 Cr
Market cap
₹5.71 Cr
Small cap
P/E
0.2
Industry 16.3
Price to book
0.16
Peers 3.73
Dividend yield
0.00%
ROE
0.5%
Peers 15.5%
ROCE
0.5%
Peers 16.6%
Debt to equity
n/a
Debt ₹0.00 Cr
EPS (TTM)
₹26.94
OPM (TTM)
−11.1%
Net margin 20.3%
Sales growth
−33.3%
Latest quarter vs a year ago
Profit growth
−137.6%
Latest quarter vs a year ago
Price to sales
13.59
EV/EBITDA 48.0

Strengths and risks

Strengths

  • Positive operating cash flow in each of the last 4 years.

Risks to check

  • Return on equity is low at 0.5%.
  • Quarterly profit down 137.6% on a year ago.
  • Quarterly sales down 33.3% on a year ago.
  • Net profit is above operating profit, so a one-off gain is likely flattering earnings.
  • 81% below its 52-week high.

Derived automatically from reported figures. Not a recommendation.

About Omkar Pharmachem

Omkar Pharmachem Limited engages in the provision of business support services in India. The company was incorporated in 1995 and is based in Ahmedabad, India.

Headquarters
Ahmedabad
Employees
4
Sector
Industrials
ISIN
INE501C01015
Website
omkarpharmachem.co.in

Price range

52 weeks

₹5.66₹29.74

Today

₹5.66₹5.66
Avg volume (3M)
1.6K
1-year return
minus 79.0%
From 52-week high
minus 81.0%

Peers · Specialty Business Services

Compare with peersScreen the whole industry
Company
BLSBLS International Services223.35minus 1.55%9,19212.93.7326.1%32.7%26.4%25.5%50.7%1.14%minus 29.5%
PDSLPDS403.90plus 0.45%5,70448.73.2316.6%6.6%2.9%6.9%−25.0%0.92%plus 6.5%
FUSIONCXFusion CX270.70minus 2.70%3,90818.15.5233.0%37.0%11.9%21.0%68.1%0.00%minus 6.5%
CMSINFOCMS Info Systems215.99minus 0.62%3,45712.21.4616.2%12.9%25.0%9.1%0.7%2.31%minus 40.0%
JAYKAYJaykay Enterprises201.05minus 4.29%3,03313.94.0830.6%40.5%10.7%72.2%220.1%0.00%minus 5.0%
LORDSMARKLord's Mark Industries70.61minus 0.51%3,01235.12.857.0%15.5%13.2%1716.6%–0.00%minus 88.9%
BLSEBLS E-Services149.81plus 1.81%2,71962.24.9016.3%12.6%6.7%66.3%44.9%0.33%plus 45.5%
OMKARPHOmkar Pharmachem5.66minus 4.87%60.20.160.5%0.5%−11.1%–−14.9%0.00%minus 79.0%
Median of 7 peers–−0.62%3,45718.13.7316.6%15.5%11.9%25.5%47.8%0.33%−6.5%

Quarterly results

Consolidated, ₹ crore
Operating profit (EBITDA)Select a row below to chart it
₹ CrJun 25Sep 25Dec 25Mar 26Jun 26
00.100−0
00000
–0–––
00000
00.100−0
25.7%25.4%25.5%23.1%–
00.100−0
0.030.050.0326.87-0.01

Profit & loss

Yearly, ₹ crore
Profit CAGR 3Y
−14.9%
EPS CAGR 3Y
−15.7%
ROE
0.5%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
0.50.5––
0.20.3––
0.30.30.30.2
57.6%–––
0000
0000
0000
0.30.30.30.2
25.2%25.2%25.6%25.2%
0.20.20.20.1
–minus 4.4%+6.2%minus 39.4%
0.200.190.200.12

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
10.110.110.110.1
−1−0.9−0.726.6
0.60.30.1–
0.10.10.10.1
9.79.69.636.7
0000
9.39.39.336.4
0.10.10.10.2
0.30.20.20.1
9.79.69.636.7

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
0.30.30.20.2
–−0−0–
−0.4−0.3−0.2−0.1
−0.1−0.100.1
–−0−0–
0.30.30.20.2

Shareholding pattern

This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.

Major shareholders

BSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you